Company profile for Ochre Bio

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Ochre Bio develops RNA therapies for chronic liver disease (a top ten cause of death) using a combination of genomics, machine learning and experimental biology on live human organs. Privately held, Ochre Bio is situated within the heart of Oxford’s biotech innovation hub.Ochre Bio was founded out of 15 years leading liver genomics research and experience in bringing advanced therapies to market. We really love what we do, a...
Ochre Bio develops RNA therapies for chronic liver disease (a top ten cause of death) using a combination of genomics, machine learning and experimental biology on live human organs. Privately held, Ochre Bio is situated within the heart of Oxford’s biotech innovation hub.Ochre Bio was founded out of 15 years leading liver genomics research and experience in bringing advanced therapies to market. We really love what we do, and are always on the lookout for new team members who aren't afraid to think

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
United Kingdom
Address
Address
Bioescalator, Oxford, GB
Telephone
Telephone
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/lexogen-successfully-completes-large-scale-human-primary-cell-next-gen-sequencing-project-with-ochre-bio-302624463.html

PR NEWSWIRE
25 Nov 2025

https://www.prnewswire.com/news-releases/new-nyc-liver-icu-lab-transforming-liver-disease-treatments-302589068.html

PR NEWSWIRE
20 Oct 2025
GSK signs AI pact with Ochre to pinpoint source of liver disease
GSK signs AI pact with Ochre to pinpoint source of liver disease

12 Jun 2024

// Annalee Armstrong FIERCE BIOTECH

https://www.fiercebiotech.com/biotech/gsk-signs-ai-pact-ochre-pinpoint-source-liver-diseases

Annalee Armstrong FIERCE BIOTECH
12 Jun 2024

https://www.ochre-bio.com/2024/04/22/ochre-bio-announces-partnership-with-boehringer-ingelheim-to-develop-novel-regenerative-treatments-for-patients-with-advanced-liver-disease/

PRESS RELEASE
23 Apr 2024

https://www.businesswire.com/news/home/20240422784860/en

BUSINESSWIRE
22 Apr 2024

https://www.businesswire.com/news/home/20230516005212/en

BUSINESSWIRE
16 May 2023

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty